1 |
Hagiwara, S.-y., M. Takahashi, Y. Shen, S. Kaihou, T. Tomiyama, M. Yazawa, Y. Tamai, Y. Sin, A. Kazusaka & M. Terazawa. 2005. A phytochemical in the edible Tamogi-take mushroom (Pleurotus cornucopiae), D-mannitol, inhibits ACE activity and lowers the blood pressure of spontaneously hypertensive rats. Bioscience, biotechnology, and biochemistry, 69: 1603-1605.
DOI
|
2 |
Ahmad, A., F. M. Anjum, T. Zahoor, H. Nawaz & S. M. R. Dilshad. 2012. Beta glucan: a valuable functional ingredient in foods. Critical reviews in food science and nutrition, 52: 201-212.
DOI
|
3 |
Ba, D. M., P. Ssentongo, R. B. Beelman, J. Muscat, X. Gao & J. P. Richie. 2021. Higher Mushroom consumption is associated with lower risk of cancer: a systematic review and meta-analysis of observational studies. Advances in Nutrition.
|
4 |
Bobek, P., E. Ginter, M. Jurcovicova & L. Kuniak. 1991. Cholesterol-lowering effect of the mushroom Pleurotus ostreatus in hereditary hypercholesterolemic rats. Annals of Nutrition and Metabolism, 35: 191-195.
DOI
|
5 |
Chen, J., J. Liu, C. Yan, C. Zhang, W. Pan, W. Zhang, Y. Lu, L. Chen & Y. Chen. 2020a. Sarcodon aspratus polysaccharides ameliorated obesity-induced metabolic disorders and modulated gut microbiota dysbiosis in mice fed a high-fat diet. Food & function, 11: 2588-2602.
DOI
|
6 |
Dubey, S. K., V. K. Chaturvedi, D. Mishra, A. Bajpeyee, A. Tiwari & M. Singh. 2019. Role of edible mushroom as a potent therapeutics for the diabetes and obesity. 3 Biotech, 9: 1-12.
DOI
|
7 |
Feng, H., S. Zhang, J. M.-F. Wan, L. Gui, M. Ruan, N. Li, H. Zhang, Z. Liu & H. Wang. 2018. Polysaccharides extracted from Phellinus linteus ameliorate high-fat high-fructose diet induced insulin resistance in mice. Carbohydrate polymers, 200: 144-153.
DOI
|
8 |
Hyder, M. S. & S. D. Dutta. 2021. Mushroom-derived polysaccharides as antitumor and anticancer agent: A concise review. Biocatalysis and Agricultural Biotechnology, 102085.
|
9 |
Chang, C.-J., C.-S. Lin, C.-C. Lu, J. Martel, Y.-F. Ko, D. M. Ojcius, S.-F. Tseng, T.-R. Wu, Y.-Y. M. Chen & J. D. Young. 2015. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nature communications, 6: 1-19.
|
10 |
Chen, L., L. Zhang, W. Wang, W. Qiu, L. Liu, A. Ning, J. Cao, M. Huang & M. Zhong .2020b. Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet. PloS one, 15: e0232972.
DOI
|
11 |
Lakhanpal, T. & M. Rana. 2005. Medicinal and nutraceutical genetic resources of mushrooms. Plant Genetic Resources, 3: 288-303.
DOI
|
12 |
Zhang, J., X. Yu, B. Xu, A. E. A. Yagoub, A. T. Mustapha & C. Zhou. 2021. Effect of intensive pulsed light on the activity, structure, physico-chemical properties and surface topography of polyphenol oxidase from mushroom. Innovative Food Science & Emerging Technologies, 102741.
|
13 |
Harrington, V., L. Lau, K. Seddu & J. Suez. 2021. Ecology and Medicine Converge at the Microbiome-Host Interface. Msystems, 6: e00756-21.
|
14 |
Sasaki, H., T. Ishizuka, M. Muto, M. Nezu, Y. Nakanishi, Y. Inagaki, H. Watanabe, H. Watanabe & M. Terada. 1998. Presence of Streptococcus anginosus DNA in esophageal cancer, dysplasia of esophagus, and gastric cancer. Cancer research, 58: 2991-2995.
|
15 |
Wu, T.-R., C.-S. Lin, C.-J. Chang, T.-L. Lin, J. Martel, Y.-F. Ko, D. M. Ojcius, C.-C. Lu, J. D. Young & H.-C. Lai. 2019. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut, 68: 248-262.
DOI
|
16 |
Chen, Y., D. Liu, D. Wang, S. Lai, R. Zhong, Y. Liu, C. Yang, B. Liu, M. R. Sarker & C. Zhao. 2019. Hypoglycemic activity and gut microbiota regulation of a novel polysaccharide from Grifola frondosa in type 2 diabetic mice. Food and Chemical Toxicology, 126: 295-302.
DOI
|
17 |
Kallus, S. J. & L. J. Brandt. 2012. The intestinal microbiota and obesity. Journal of clinical gastroenterology, 46: 16-24.
DOI
|
18 |
Kim, G.-Y., G.-S. Choi, S.-H. Lee & Y.-M. Park. 2004. Acidic polysaccharide isolated from Phellinus linteus enhances through the up-regulation of nitric oxide and tumor necrosis factor-α from peritoneal macrophages. Journal of Ethnopharmacology, 95: 69-76.
DOI
|
19 |
Li, X., F. Zeng, Y. Huang & B. Liu. 2019b. The positive effects of Grifola frondosa heteropolysaccharide on NAFLD and regulation of the gut microbiota. International journal of molecular sciences, 20: 5302.
DOI
|
20 |
Liu, Y., C. Wang, J. Li, T. Li, Y. Zhang, Y. Liang & Y. Mei. 2020. Phellinus linteus polysaccharide extract improves insulin resistance by regulating gut microbiota composition. The FASEB Journal, 34: 1065-1078.
DOI
|
21 |
Lv, X.-C., W.-L. Guo, L. Li, X.-D. Yu & B. Liu. 2019. Polysaccharide peptides from Ganoderma lucidum ameliorate lipid metabolic disorders and gut microbiota dysbiosis in high-fat diet-fed rats. Journal of Functional Foods, 57: 48-58.
DOI
|
22 |
John, G. K. & G. E. Mullin. 2016. The gut microbiome and obesity. Current oncology reports, 18: 1-7.
DOI
|
23 |
Lee, J. E., S. Lee, H. Lee, Y.-M. Song, K. Lee, M. J. Han, J. Sung & G. Ko. 2013. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PloS one, 8: e63514.
DOI
|
24 |
Zhao, S., Q. Gao, C. Rong, S. Wang, Z. Zhao, Y. Liu & J. Xu. 2020. Immunomodulatory effects of edible and medicinal mushrooms and their bioactive immunoregulatory products. Journal of Fungi, 6: 269.
DOI
|
25 |
Guo, W.-L., J.-C. Deng, Y.-Y. Pan, J.-X. Xu, J.-L. Hong, F.-F. Shi, G.-L. Liu, M. Qian, W.-D. Bai & W. Zhang. 2020. Hypoglycemic and hypolipidemic activities of Grifola frondosa polysaccharides and their relationships with the modulation of intestinal microflora in diabetic mice induced by high-fat diet and streptozotocin. International journal of biological macromolecules, 153: 1231-1240.
DOI
|
26 |
Jesenak, M., J. Majtan, Z. Rennerova, J. Kyselovic, P. Banovcin & M. Hrubisko. 2013. Immunomodulatory effect of pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections. International Immunopharmacology, 15: 395-399.
DOI
|
27 |
Chen, M., D. Xiao, W. Liu, Y. Song, B. Zou, L. Li, P. Li, Y. Cai, D. Liu & Q. Liao. 2020c. Intake of Ganoderma lucidum polysaccharides reverses the disturbed gut microbiota and metabolism in type 2 diabetic rats. International journal of biological macromolecules, 155: 890-902.
DOI
|
28 |
Davies, C., D. Mishra, R. S. Eshraghi, J. Mittal, R. Sinha, E. Bulut, R. Mittal & A. A. Eshraghi. 2021. Altering the gut microbiome to potentially modulate behavioral manifestations in autism spectrum disorders: A systematic review. Neuroscience & Biobehavioral Reviews, 128: 549-557.
DOI
|
29 |
Diamandis, E. P. 2014. Present and future of cancer biomarkers. Clinical Chemistry and Laboratory Medicine (CCLM), 52: 791-794.
DOI
|
30 |
Khatun, K., H. Mahtab, P. Khanam, M. Sayeed & K. Khan. 2007. Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects. Mymensingh medical journal: MMJ, 16: 94-99.
|
31 |
Lin, J.-Y., T.-W. Jeng, C.-C. Chen, G.-Y. Shi & T.-C. Tung. 1973. Isolation of a new cardiotoxic protein from the edible mushroom, Volvariella volvacea. Nature, 246: 524-525.
DOI
|
32 |
Ma, G., H. Du, Q. Hu, W. Yang, F. Pei & H. Xiao. 2021. Health benefits of edible mushroom polysaccharides and associated gut microbiota regulation. Critical Reviews in Food Science and Nutrition, 1-18.
|
33 |
Mariat, D., O. Firmesse, F. Levenez, V. Guimaraes, H. Sokol, J. Dore, G. Corthier & J. Furet. 2009. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC microbiology, 9: 1-6.
DOI
|
34 |
Park, J. W., H. Y. Kim, M. G. Kim, S. Jeong, C.-H. Yun & S. H. Han. 2019. Short-chain fatty acids inhibit staphylococcal lipoprotein-induced nitric oxide production in murine macrophages. Immune network, 19.
|
35 |
Harshavardhini, B. & P. D. Sharma. 2021. Drying Characteristics of Button Mushroom. Int. J. Curr. Microbiol. App. Sci, 10: 503-512.
DOI
|
36 |
Ooi, V. E. C. & F. Liu. 1999. A review of pharmacological activities of mushroom polysaccharides. International Journal of medicinal mushrooms, 1.
|
37 |
Muthuramalingam, K., V. Singh, C. Choi, S. I. Choi, S. Park, Y. M. Kim, T. Unno & M. Cho. 2019. Effect of mushroom (Schizophyllum spp.) derived β-glucan on low-fiber diet induced gut dysbiosis. Journal of Applied Biological Chemistry, 62: 211-217.
DOI
|
38 |
Nichols, R. G. & E. R. Davenport. 2021. The relationship between the gut microbiome and host gene expression: a review. Human genetics, 140: 747-760.
DOI
|
39 |
Ohno, N., S. Nameda, T. Harada, N. N. Miura, Y. Adachi, M. Nakajima, K. Yoshida, H. Yoshida & T. Yadomae. 2003. Immunomodulating Activity of a b-Glucan Preparation, SCG, Extracted from a Culinary-Medicinal Mushroom, Sparassis crispa Wulf.: Fr.(Aphyllophoromycetideae), and Application to Cancer Patients. International Journal of Medicinal Mushrooms, 5.
|
40 |
Narikiyo, M., C. Tanabe, Y. Yamada, H. Igaki, Y. Tachimori, H. Kato, M. Muto, R. Montesano, H. Sakamoto & Y. Nakajima. 2004. Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers. Cancer science, 95: 569-574.
DOI
|
41 |
Tong, A. J., R. K. Hu, L. X. Wu, X. C. Lv, X. Li, L. N. Zhao & B. Liu. 2020. Ganoderma polysaccharide and chitosan synergistically ameliorate lipid metabolic disorders and modulate gut microbiota composition in high fat diet-fed golden hamsters. Journal of food biochemistry, 44: e13109.
|
42 |
Fang, J., Y. Wang, X. Lv, X. Shen, X. Ni & K. Ding. 2012. Structure of a β-glucan from Grifola frondosa and its antitumor effect by activating Dectin-1/Syk/NF-κB signaling. Glycoconjugate journal, 29: 365-377.
DOI
|
43 |
Grivennikov, S. I., K. Wang, D. Mucida, C. A. Stewart, B. Schnabl, D. Jauch, K. Taniguchi, G.-Y. Yu, C. H. Osterreicher & K. E. Hung. 2012. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature, 491: 254-258.
DOI
|
44 |
Alves, M. J., I. C. Ferreira, J. Dias, V. Teixeira, A. Martins & M. Pintado. 2012. A review on antimicrobial activity of mushroom (Basidiomycetes) extracts and isolated compounds. Planta medica, 78: 1707-1718.
DOI
|
45 |
Anderson, L. A., S. J. Murphy, B. T. Johnston, R. Watson, H. Ferguson, K. B. Bamford, A. Ghazy, P. McCarron, J. McGuigan & J. V. Reynolds. 2008. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut, 57: 734-739.
DOI
|
46 |
Fernandez-Julia, P., J. Munoz-Munoz & D. van Sinderen. 2021. A comprehensive review on the impact of β-glucan metabolism by Bacteroides and Bifidobacterium species as members of the gut microbiota. International Journal of Biological Macromolecules.
|
47 |
Guo, X., X. Xia, R. Tang, J. Zhou, H. Zhao & K. Wang. 2008. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Letters in applied microbiology, 47: 367-373.
DOI
|
48 |
Farrell, J. J., L. Zhang, H. Zhou, D. Chia, D. Elashoff, D. Akin, B. J. Paster, K. Joshipura & D. T. Wong. 2012. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut, 61: 582-588.
DOI
|
49 |
BHAT, Z. A., A. H. WANI, J. M. WAR & M. Y. BHAT. 2021. MAJOR BIOACTIVE PROPERTIES OF GANODERMA POLYSACCHARIDES: A REVIEW. Asian J Pharm Clin Res, 14: 11-24.
|
50 |
Barea-Sepulveda, M., E. Espada-Bellido, M. Ferreiro-Gonzalez, A. Benitez-Rodriguez, J. G. Lopez-Castillo, M. Palma & G. F. Barbero. 2021. Metal concentrations in Lactarius mushroom species collected from Southern Spain and Northern Morocco: Evaluation of health risks and benefits. Journal of Food Composition and Analysis, 99: 103859.
DOI
|
51 |
Macfarlane, S., E. Furrie, G. T. Macfarlane & J. F. Dillon. 2007. Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus. Clinical infectious diseases, 45: 29-38.
DOI
|
52 |
Mager, D., A. Haffajee, P. Devlin, C. Norris, M. Posner & J. Goodson. 2005. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. Journal of translational medicine, 3: 1-8.
DOI
|
53 |
Mishra, R. R., M. Tewari & H. S. Shukla. 2011. Helicobacter pylori and pathogenesis of gallbladder cancer. Journal of gastroenterology and hepatology, 26: 260-266.
DOI
|
54 |
Muller, L. B., R. B. Fagundes, C. C. d. Moraes & A. Rampazzo. 2007. Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia. Arquivos de gastroenterologia, 44: 93-98.
DOI
|
55 |
Nakahara, D., C. Nan, K. Mori, M. Hanayama, H. Kikuchi, S. Hirai & Y. Egashira. 2020. Effect of mushroom polysaccharides from Pleurotus eryngii on obesity and gut microbiota in mice fed a high-fat diet. European journal of nutrition, 59: 3231-3244.
DOI
|
56 |
Yin, C., G. D. Noratto, X. Fan, Z. Chen, F. Yao, D. Shi & H. Gao. 2020. The impact of mushroom polysaccharides on gut microbiota and its beneficial effects to host: A review. Carbohydrate Polymers, 116942.
DOI
|
57 |
Nowakowski, P., R. Markiewicz-Zukowska, J. Bielecka, K. Mielcarek, M. Grabia & K. Socha. 2021. Treasures from the forest: Evaluation of mushroom extracts as anti-cancer agents. Biomedicine & Pharmacotherapy, 143: 112106.
DOI
|
58 |
Pan, Y., X. Wan, F. Zeng, R. Zhong, W. Guo, X.-C. Lv, C. Zhao & B. Liu. 2020. Regulatory effect of Grifola frondosa extract rich in polysaccharides and organic acids on glycolipid metabolism and gut microbiota in rats. International journal of biological macromolecules, 155: 1030-1039.
DOI
|
59 |
Nitschke, J., H. Modick, E. Busch, R. W. Von Rekowski, H.-J. Altenbach & H. Molleken. 2011. A new colorimetric method to quantify β-1, 3-1, 6-glucans in comparison with total β-1, 3-glucans in edible mushrooms. Food chemistry, 127: 791-796.
DOI
|
60 |
Ser, H.-L., V. Letchumanan, B.-H. Goh, S. H. Wong & L.-H. Lee. 2021.The Use of Fecal Microbiome Transplant in Treating Human Diseases: Too Early for Poop? Frontiers in Microbiology, 12: 1005.
|
61 |
Seo, D. J. & C. Choi. 2021. Antiviral bioactive compounds of mushrooms and their antiviral mechanisms: a review. Viruses, 13: 350.
DOI
|
62 |
Usman, M., G. Murtaza & A. Ditta. 2021. Nutritional, Medicinal, and Cosmetic Value of Bioactive Compounds in Button Mushroom (Agaricus bisporus): A Review. Applied Sciences, 11: 5943.
DOI
|
63 |
Wasser, S. 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied microbiology and biotechnology, 60: 258-274.
DOI
|
64 |
Wasser, S. P. & A. L. Weis. 1999. Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspectives. International Journal of medicinal mushrooms, 1.
|
65 |
Schmitt, M., C. Depuydt, I. Benoy, J. Bogers, J. Antoine, M. Pawlita & M. Arbyn. 2013b. Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions. Cancer Epidemiology and Prevention Biomarkers, 22: 406-414.
DOI
|
66 |
Priyadarshini, M., K. Lednovich, K. Xu, S. Gough, B. Wicksteed & B. T. Layden. 2021. FFAR from the Gut Microbiome Crowd: SCFA Receptors in T1D Pathology. Metabolites, 11: 302.
DOI
|
67 |
Sasaki, M., C. Yamaura, Y. Ohara-Nemoto, S. Tajika, Y. Kodama, T. Ohya, R. Harada & S. Kimura. 2005. Streptococcus anginosus infection in oral cancer and its infection route. Oral diseases, 11: 151-156.
DOI
|
68 |
Schmitt, M., C. Depuydt, I. Benoy, J. Bogers, J. Antoine, M. Arbyn, M. Pawlita & V. S. Group. 2013a. Prevalence and viral load of 51 genital human papillomavirus types and three subtypes. International journal of cancer, 132: 2395-2403.
DOI
|
69 |
Sharma, V., V. S. Chauhan, G. Nath, A. Kumar & V. K. Shukla. 2007. Role of bile bacteria in gallbladder carcinoma. Hepatogastroenterology, 54: 1622-1625.
|
70 |
Shen, X. J., J. F. Rawls, T. A. Randall, L. Burcall, C. Mpande, N. Jenkins, B. Jovov, Z. Abdo, R. S. Sandler & T. O. Keku. 2010. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut microbes, 1: 138-147.
DOI
|
71 |
Li, L., W.-L. Guo, W. Zhang, J.-X. Xu, M. Qian, W.-D. Bai, Y.-Y. Zhang, P.-F. Rao, L. Ni & X.-C. Lv. 2019a. Grifola frondosa polysaccharides ameliorate lipid metabolic disorders and gut microbiota dysbiosis in high-fat diet fed rats. Food & function, 10: 2560-2572.
DOI
|
72 |
Xu, S., Y. Dou, B. Ye, Q. Wu, Y. Wang, M. Hu, F. Ma, X. Rong & J. Guo. 2017. Ganoderma lucidum polysaccharides improve insulin sensitivity by regulating inflammatory cytokines and gut microbiota composition in mice. Journal of Functional Foods, 38: 545-552.
DOI
|
73 |
Xu, Y., M. Shen, Y. Chen, Y. Lou, R. Luo, J. Chen, Y. Zhang, J. Li & W. Wang. 2018. Optimization of the polysaccharide hydrolysate from Auricularia auricula with antioxidant activity by response surface methodology. International journal of biological macromolecules, 113: 543-549.
DOI
|
74 |
Chakraborty, N., A. Banerjee, A. Sarkar, S. Ghosh & K. Acharya . 2021. Mushroom polysaccharides: A potent immunemodulator. Biointerface Research in Applied Chemistry, 11: 8915-8930.
DOI
|
75 |
Vaishampayan, P. A., J. V. Kuehl, J. L. Froula, J. L. Morgan, H. Ochman & M. P. Francino. 2010. Comparative metagenomics and population dynamics of the gut microbiota in mother and infant. Genome biology and evolution, 2: 53-66.
DOI
|
76 |
Shan-Shan, S., W. Kai, M. Ke, B. Li & L. Hong-Wei. 2019. An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota. Chinese journal of natural medicines, 17: 3-14.
DOI
|
77 |
Sobhani, I., J. Tap, F. Roudot-Thoraval, J. P. Roperch, S. Letulle, P. Langella, G. Corthier, J. T. Van Nhieu & J. P. Furet. 2011. Microbial dysbiosis in colorectal cancer (CRC) patients. PloS one, 6: e16393.
DOI
|
78 |
Swidsinski, A., M. Khilkin, D. Kerjaschki, S. Schreiber, M. Ortner, J. Weber & H. Lochs. 1998. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology, 115: 281-286.
DOI
|
79 |
Zhang, P. & P. C. Cheung. 2002. Evaluation of sulfated Lentinus edodes α-(1→3)-d-glucan as a potential antitumor agent. Bioscience, biotechnology, and biochemistry, 66: 1052-1056.
DOI
|
80 |
Yamanaka, D., M. Shoda, T. Matsubara, K.-i. Ishibashi, A. Motoi, R. Motoi, M. Motoi, N. Ohno & Y. Adachi. 2021. Open-Label Study of the Influence of Food Containing the Royal Sun Mushroom, Agaricus brasiliensis KA21 (Agaricomycetes), on β-Glucan-Specific Antibody Production in Healthy Human Volunteers. International Journal of Medicinal Mushrooms, 23.
|
81 |
Patel, D. K., S. D. Dutta, K. Ganguly, S.-J. Cho & K.-T. Lim. 2021. Mushroom-derived bioactive molecules as immunotherapeutic agents: A review. Molecules, 26: 1359.
DOI
|
82 |
Stojanov, S., A. Berlec & B. Strukelj. 2020. The influence of probiotics on the Firmicutes/Bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms, 8: 1715.
DOI
|
83 |
Sun, S., Y. Yang, X. Lin, P. Chen, L. Ye, L. Zeng, Q. Ye, X. Yang, J. Ceng & J. Shan. 2021. Qiweibaizhu Decoction Treats Diarrheal Juvenile Rats by Modulating the Gut Microbiota, Short-Chain Fatty Acids, and the Mucus Barrier. Evidence-Based Complementary and Alternative Medicine, 2021.
|